Abstract:The combination of synthetic and systems biology is a powerful framework to study fundamental questions in biology and produce chemicals of immediate practical application such as biofuels, polymers, or therapeutics. However, we cannot yet engineer biological systems as easily and precisely as we engineer physical systems. In this review, we describe the path from the choice of target molecule to scaling production up to commercial volumes. We present and explain some of the current challenges and gaps in our knowledge that must be overcome in order to bring our bioengineering capabilities to the level of other engineering disciplines. Challenges start at molecule selection, where a difficult balance between economic potential and biological feasibility must be struck. Pathway design and construction have recently been revolutionized by next-generation sequencing and exponentially improving DNA synthesis capabilities. Although pathway optimization can be significantly aided by enzyme expression characterization through proteomics, choosing optimal relative protein expression levels for maximum production is still the subject of heuristic, non-systematic approaches. Toxic metabolic intermediates and proteins can significantly affect production, and dynamic pathway regulation emerges as a powerful but yet immature tool to prevent it. Host engineering arises as a much needed complement to pathway engineering for high bioproduct yields; and systems biology approaches such as stoichiometric modeling or growth coupling strategies are required. A final, and often underestimated, challenge is the successful scale up of processes to commercial volumes. Sustained efforts in improving reproducibility and predictability are needed for further development of bioengineering.

Production of pyrimidine nucleosides in microbial systems via metabolic engineering: Theoretical analysis research and prospects

Microbial Synthesis of Nucleosides: Advances and Prospects

In silico-guided metabolic engineering of Bacillus subtilis for efficient biosynthesis of purine nucleosides by blocking the key backflow nodes

Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

Strategies for microbial synthesis of high-value phytochemicals

Harnessing synthetic biology-based strategies for engineered biosynthesis of nucleoside natural products in actinobacteria

Microbial Cell Factory for Efficiently Synthesizing Plant Natural Products via Optimizing the Location and Adaptation of Pathway on Genome Scale

Current research status and vistas on metabolic engineering of nucleoside antibiotics

Advanced Strategies for Production of Natural Products in Yeast

Systems metabolic engineering of microorganisms to achieve large-scale production of flavonoid scaffolds.

Metabolic engineering of microorganisms: general strategies and drug production

Metabolic Engineering of Streptomyces to Enhance the Synthesis of Valuable Natural Products

Recent advances in microbial production of high-value compounds in the tetrapyrrole biosynthesis pathway

Synthetic biology-inspired strategies and tools for engineering of microbial natural product biosynthetic pathways

Interfacing a phosphate catalytic reaction with a microbial metabolism for the production of azaphilone alkaloids

Microbial synthetic biology for plant metabolite production: a strategy to reconcile human health with the realization of the UN Sustainable Development Goals

Metabolic Engineering of Microorganisms for the Production of Flavonoids

Present Situation and Prospect for Production Technology of Nucleotide

Synthetic and systems biology for microbial production of commodity chemicals

Cell-Free Biosynthesis System: Methodology and Perspective of in Vitro Efficient Platform for Pyruvate Biosynthesis and Transformation.